We are live on
!
Find out more
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
17 hedge funds and large institutions have $3.55M invested in Interpace Biosciences, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding
Funds holding: 17 → 17 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
37% less capital invested
Capital invested by funds: $5.66M → $3.55M (-$2.1M)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Holders
17
Holders Change
–
Holders Change %
0%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VF
Virtu Financial
New York
|
+$55.8K |
| 2 |
WS
Wedbush Securities
Los Angeles,
California
|
+$17.2K |
| 3 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$15.3K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$11.8K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$5.05K |
